Press Coverage

Peer-Reviewed Study Demonstrates the Use of DuraGraft May Reduce VGF-related Complications Post-CABG

January 22, 2019 - Somahlution’s peer-reviewed publication suggests CABG patients may benefit long-term clinical outcomes following surgery when treated with DuraGraft; First-in-class intraoperative vascular graft treatment shown to reduce the risk of graft failure. [...]

Somahlution Announces European Hospital in Rome to Participate in European DuraGraft® Registry

March 27, 2018 - Somahlution Announces European Hospital in Rome to Participate in European DuraGraft® Registry [...]

Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry

February 12, 2018 - Somahlution Announces Site Initiation and Patient Enrollment in United Kingdom for European DuraGraft Registry [...]

Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany

May 26, 2017 - Somahlution Announces DuraGraft Registry Initiation at Leading Cardiac Surgery Hospitals in Germany [...]

Somahlution Announces Medical University of Vienna as First Austrian Site to Participate in DuraGraft Registry

May 5, 2017 - Somahlution Announces Medical University of Vienna as First Austrian Site to Participate in DuraGraft Registry [...]

Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry

February 1, 2017 - Somahlution Announces Multiple Site Initiation and Patient Enrollment in Spain for European DuraGraft Registry [...]

Research Shows Promising Long-Term Outcomes For New Vascular Graft Treatment

Somahlution recently released results of a study on long-term outcomes in procedures using their vascular graft treatment product, Duragraft. The company, based in Jupiter, Florida, is celebrating the highly encouraging results [...]

Novel treatment to prevent vein graft failure confers improved outcomes after CABG

Researchers conducted a retrospective, nonrandomized real-world study of 2,436 patients who had CABG with at least one saphenous vein graft. In the cohort, 1,036 were treated with the vascular graft treatment designed to protect [...]

DuraGraft Vascular Graft Evaluated to Prevent Vein Graft Failure After CABG

Dr. Haime discusses an abstract about Somahlution DuraGraft during a rapid response session at the 2016 annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS; 1–5 October, Barcelona, Spain) [...]

Intraoperative Vascular Graft Treatment Shown to Reduce Risk of Graft Failure

Somahlution, a global biotechnology company leading the development of products to reduce the burden of ischemia reperfusion injury in tissue grafting, organ transplant and other surgical indications, today announced presentation [...]

EACTS 2016: DuraGraft vascular graft treatment improves long-term outcomes after CABG

Somahlution announced the presentation of new data showing the its DuraGraft vascular graft treatment significantly improves long-term outcomes in coronary artery bypass grafting (CABG) surgery. Results were presented today [...]

Somahlution Reveals Positive Study Results Showing Efficacy of DuraGraft

Somahlution's DuraGraft vascular graft treatment significantly improves long-term outcomes in coronary artery bypass grafting (CABG) surgery, the company said at the European Association for Cardio-Thoracic Surgery [...]